Nontoxic Suramin as a Chemosensitizer in Patients: Dosing Nomogram Development-Reference-Cited by-同舟云学术

Nontoxic Suramin as a Chemosensitizer in Patients: Dosing Nomogram Development

Published:2006-05-25 Issue:6 Volume:23 Page:1265-1274
ISSN:0724-8741
Container-title:Pharmaceutical Research
language:en
Short-container-title:Pharm Res

Author:

Chen Danny,Song Sae Heum,Wientjes M. Guillaume,Yeh Teng Kuang,Zhao Liang,Villalona-Calero Miguel,Otterson Gregory A.,Jensen Rhonda,Grever Michael,Murgo Anthony J.,Au Jessie L-S.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology

Link

http://link.springer.com/content/pdf/10.1007/s11095-006-0165-1.pdf

Reference43 articles.

1. Fibroblast growth factors: An epigenetic mechanism of broad spectrum resistance to anticancer drugs

2. Suramin, an anti-cancer drug, inhibits protein kinase C and induces differentiation in neuroblastoma cell clone NB2A

3. Suramin interference with transforming growth factor-β inhibition of human renal cell carcinoma in culture

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of invariant surface glycoprotein 75 in xenobiotic acquisition by African trypanosomes;Microbial Cell;2023-02-06

2. Corneal Neovascularization: A Combined Approach of Bevacizumab and Suramin Showed Increased Antiangiogenic Effect Through Downregulation of BFGF and P2X2;Current Eye Research;2017-12-21

3. Suramin;Meyler's Side Effects of Drugs;2016

4. Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanes;Cancer Chemotherapy and Pharmacology;2012-05-22

5. Therapeutic drug monitoring in cancer chemotherapy;Bioanalysis;2010-05